TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Xellia Pharmaceuticals ApS
Closing information (x1000 SEK)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover | 3,360,059 | 2,465,340 | 2,755,833 |
Earnings before taxes | -381,008 | -605,104 | -184,245 |
Total assets | 5,178,202 | 5,134,834 | 5,519,644 |
Current assets | 1,602,580 | 1,801,358 | 2,302,934 |
Current liabilities | 1,639,291 | 1,249,492 | 932,737 |
Equity capital | 2,619,856 | 2,864,317 | 3,536,386 |
- share capital | 300,793 | 276,429 | 271,196 |
Employees (average) | 350 | 350 | 350 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency | 50.6% | 55.8% | 64.1% |
Turnover per employee | 9,600 | 7,044 | 7,874 |
Profit as a percentage of turnover | -11.3% | -24.5% | -6.7% |
Return on assets (ROA) | |||
Current ratio | 97.8% | 144.2% | 246.9% |
Return on equity (ROE) | -14.5% | -21.1% | -5.2% |
Change turnover | 677,424 | -343,664 | -409,872 |
Change turnover % | 25% | -12% | -13% |
Chg. No. of employees | 0 | 0 | 0 |
Chg. No. of employees % | 0% | 0% | 0% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.